DrugInformer Search

Taztia Xt

Average User Review Score
* Based on 1 reviews from across the web.

Diltiazem (INN) (/dɪlˈtaɪəzɛm/) is a nondihydropyridines (non-DHP) calcium channel blocker used in the treatment of hypertension, angina pectoris, and some types of arrhythmia. It relaxes the smooth muscles in the walls of arteries, which opens (dilates) the arteries, allows blood to flow more easily, and lowers blood pressure. Additionally, it lowers blood pressure by acting on the heart itself to reduce the rate, strength, and conduction speed of each beat.

Read more on Wikipedia

  Please use Workbench for in-depth research on Taztia Xt.

* Extracted from FDA Adverse Event Reports for all drugs with the same active ingredients.

Tell us about your Experience with Taztia Xt

Thank you for sharing your experience with us!

Share Your Experience

Druginformer Identified Side Effects: Headache, Dizziness, Palpitations, Cardiac flutter, Vision blurred

Posted By Anonymous in www.everydayhealth.com on November 25, 2013 @ 12:00 am

umerous side effects including blurred vision,dizziness,heart palpations and continued flutter.minor headaches as well.not well tolerated by me.have been taking for 2 months and I feel like I have gi...

Druginformer Identified Side Effects: None

Posted By kmack3211 in drugs.com on March 8, 2008 @ 12:00 am

Loss of sexual pleasure In the last several months there has been a noticable drop in maintaining an erection and reaching orgasms. I am male who is taking what I feel is way too many drugs for hyper...

* Warning: The facts and figures contained in these reports are accurate to the best of our capability; however, our metrics are only meant to augment your medical knowledge, and should never be used as the sole basis for selecting a new medication. As with any medical decision, be sure to work with your doctor to ensure the best choices are made for your condition.

* About FAERS: The FDA Adverse Event Reporting System (FAERS) is used by FDA for activities such as looking for new safety concerns that might be related to a marketed product, evaluating a manufacturer's compliance to reporting regulations and responding to outside requests for information. Reporting of adverse events is a voluntary process, and not every report is sent to FDA and entered into FAERS. The FAERS database may contain duplicate reports, the report quality is variable, and many factors may influence reporting (e.g., media attention, length of time a drug is marketed, market share). For these reasons, FAERS case reports cannot be used to calculate incidence or estimates of risk for a particular product or compare risks between products.